3 FTSE 100 Stocks To Buy On St. Leger Day: Barclays PLC, GlaxoSmithKline plc & Vodafone Group plc

Here’s why Barclays PLC (LON: BARC), GlaxoSmithKline plc (LON: GSK) and Vodafone Group plc (LON: VOD) could be worth buying right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

‘Sell in May and don’t come back until St. Leger Day’ is a well-known stock-market saying. In other words, sell shares in May and buy when the St. Leger Day races commence in early September. The reason for the saying is that summer rallies tend to be infrequent and, in fact, history suggests that a summer pullback is not at all uncommon. Indeed, the FTSE 100 is no higher now than it was in May 2014, so those investors who sold up and went away have not missed out on any gains.

However, it’s now early September and, with the FTSE 100 still failing to push past 7,000 points, this could be a great time to buy the following three stocks.

Barclays

Since the start of May, Barclays (LSE: BARC) has seen its share price fall by 11% as investor sentiment has severely weakened. While this week’s news of a £500 million loss on the sale of part of its Spanish operations may seem like yet more bad news, Barclays continues to make good progress with its disposal programme. Certainly, this will cause short-term pain, but may also set the bank up for improved profitability moving forward.

With shares in the bank trading on a price to earnings (P/E) ratio of just 10.3 and Barclays being forecast to increase its bottom line by an impressive 25% next year, the presently low ebb in sentiment could prove to be an ideal buying opportunity.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) is also down 11% since the start of May, with shares in the pharmaceutical major continuing to be hit hard by allegations of bribery. Long-term investors, though, should see this as a buying opportunity as opposed to a reason to panic.

GlaxoSmithKline continues to have a hugely impressive and diversified drugs pipeline which, in the long run, should help the company to considerably grow its bottom line. Furthermore, shares in the company are priced to sell, with GlaxoSmithKline trading on a P/E ratio of just 13 and offering a stunning yield of 5.6%. As with Barclays, weak sentiment could equate to a superb buying opportunity.

Vodafone

It’s a similar story with Vodafone (LSE: VOD): you’d have been better off selling at the start of May, since shares in the company have fallen by 8% since then. However, the future could be much brighter than the past for the European-focused operator, with its strategy of buying undervalued Eurozone assets taking time to come good.

However, should it do so, Vodafone could see its bottom line grow at an impressive rate as it has bought high-quality assets at very attractive prices. In addition, shares in Vodafone currently yield 5.5%, which highlights the company’s income potential at a time when low interest rates look set to be the ‘new normal’.

 

Peter Stephens owns shares of Barclays and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Down 35% in 2 months! Should I buy NIO stock at $5?

NIO stock has plunged in recent weeks, losing a third of its market value despite surging sales. Is this EV…

Read more »

Two employees sat at desk welcoming customer to a Tesla car showroom
Investing Articles

Could 2026 be the year when Tesla stock implodes?

Tesla's 2025 business performance has been uneven. But Tesla stock has performed well overall and more than doubled since April.…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Could these FTSE 100 losers be among the best stocks to buy in 2026?

In the absence of any disasters, Paul Summers wonders if some of the worst-performing shares in FTSE 100 this year…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Up 184% this year, what might this FTSE 100 share do in 2026?

This FTSE 100 share has almost tripled in value since the start of the year. Our writer explains why --…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

You can save £100 a month for 30 years to target a £2,000 a year second income, or…

It’s never too early – or too late – to start working on building a second income. But there’s a…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Forget Rolls-Royce shares! 2 FTSE 100 stocks tipped to soar in 2026

Rolls-Royce's share price is expected to slow rapidly after 2025's stunning gains. Here are two top FTSE 100 shares now…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Brokers think this 83p FTSE 100 stock could soar 40% next year!

Mark Hartley takes a look at the factors driving high expectations for one major FTSE 100 retail stock – is…

Read more »

Investing Articles

I asked ChatGPT for the best FTSE 100 shares to consider for 2026, and it said…

Whatever an individual investor's favourite strategy, I reckon there's something for everyone among the shares in the FTSE 100.

Read more »